BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 19530913)

  • 1. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
    Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
    Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
    Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
    Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
    Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Patil Y; Panyam J
    Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
    J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells.
    Wang C; Ho PC; Lim LY
    Int J Pharm; 2010 Nov; 400(1-2):201-10. PubMed ID: 20804835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biodistribution of paclitaxel-loaded microspheres.
    Yan F; Tang S; Fu Q
    Arzneimittelforschung; 2012 Apr; 62(4):176-80. PubMed ID: 22270845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
    J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of modification of transferrin on cytotoxicity and intracellular delivery of paclitaxel loaded PLGA nanoparticles].
    Jin SH; Li NC; Zhang ZH; Na YQ
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3151-4. PubMed ID: 23328431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
    Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
    Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.